Can an athlete have too much ticker? Hypertrophic cardiomyopathy in young athletes

Nicholas M Fitzgerald1, Megan Sherwood, Dominic A Fitzgerald

  • 1University of New South Wales Medical School, Sydney, New South Wales, Australia.

Insights

Sudden cardiac death in young athletes is often caused by hypertrophic cardiomyopathy (HCM). Screening for HCM can reduce mortality but incurs substantial economic costs, necessitating a balanced approach to athlete safety and healthcare resources.

Area of Science:

  • Cardiology
  • Sports Medicine
  • Genetics

Background:

  • Sudden cardiac death (SCD) is a rare but severe risk in adolescent and young adult athletes.
  • Hypertrophic cardiomyopathy (HCM), a genetic heart condition, is the leading cause of SCD in this population.
  • HCM is a manageable condition with early diagnosis.

Purpose of the Study:

  • To present evidence and arguments for and against screening for HCM in athletes.
  • To discuss current screening strategies employed in Europe and North America.
  • To outline management strategies for HCM, illustrated with a case study.

Main Methods:

  • Review of evidence regarding HCM screening in athletes.
  • Analysis of arguments supporting and opposing current screening protocols.
  • Presentation of a clinical case to illustrate management.

Main Results:

  • Screening and early diagnosis of HCM have demonstrably reduced mortality rates in athletes.
  • Current screening strategies differ between Europe and North America.
  • Screening programs for HCM are associated with significant economic costs.

Conclusions:

  • While screening effectively reduces SCD mortality, its high economic cost requires careful consideration.
  • Balancing the benefits of early detection against financial implications is crucial for implementing effective HCM screening programs.
  • Further evaluation of screening strategies and management protocols for HCM in athletes is warranted.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...